Recombinant DNA technology, in which a large quantity of proteins are produced through the insertion of the desired protein gene into an expression vector which must contain a promoter so that the protein is expressed.
HISTORY: 1796:
First protein vaccine produced (cow
pox vaccine) by EDWARD JENNER 1922:First protein pharmaceutical produced (insulin) by BANTING and BEST 1970s:Recombinant biotechnology flourished due to discovery of recombinant DNA by BERG , COHEN and BOYER 1990s: Many enzymes produced by recombinant techniques
1993s:
50% of industrial enzymes
provided by recombinant processes. Mouse cells are used in the bio manufacturing of recombinant proteins (Barnes et al.2000)& also function as feeder cells for embryonic stem cells. 2009, the number of protein-Based recombinant pharmaceuticals lincensed by the US food and drug administration.
IMPORTANCE: Products
of these industries in turn augment
the fields of medicine, diagnostics, food, nutrition, detergents, textile, leather, paper, pulp and skin care products. Recombinant proteins benefit major sectors of the -Biopharmaceutical industry -Enzymes industry -Agricultural industry -Food and fermentation industry